Author,Title,Journal,ISSN,Publisher,Date,Volume,Number,Page,URL,URL(DOI)
SOLIMAN MM,Rituximab or a second anti-tumor necrosis factor for rheumatoid arthritis patients who have failed their first antitumor necrosis factor therapy? Comparative analysis from the British Society for Rheumatology Biologics Register,Arthritis Care Res,,,2012,64,8,1108-1115,https://cir.nii.ac.jp/crid/1570572701398967424,